The protein vaccine system (OVA + CpG) designed for melanoma not only prevents tumor formation, but also improves survival benefit after combining romidesine (HDAC inhibitor)-IBET151 (BET inhibitor) [226]. The gene discussed is HDAC9; the disease is neoplasm.